The agency is requiring Tom's to submit several documents, including assessments and remediation plans for its operations, contamination hazards, testing methods and more.

Remnants of Hurricane Helene shut down a North Carolina factory that supplies critical IV fluids to hospitals across the country. There's no timeline for when production will resume at the facility.

Chemicals used in food packaging and linked with health problems have been detected in the human body. The chemicals can move from packaging into food.

Members of the Democratic Women's Caucus are urging the FDA to address concerns about the safety and regulation of tampons after a study found heavy metals, including lead, in many popular products.

The Food and Drug Administration gave the green light to two updated COVID-19 vaccines to protect against recent variants of the coronavirus.

The much-anticipated decision has rattled supporters of psychedelic therapies. The drugmaker says it will ask the agency to reconsider.

No illnesses have been reported in connection to the alerts. The FDA has recommended that manufacturers voluntarily recall their products.

More than 150 people across more than 20 states have fallen ill after being exposed to cucumbers that were possibly contaminated with salmonella, the CDC said Wednesday. No deaths have been reported.

Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.

It is unclear why the suggested rule was not released by its intended deadline. But a spokesperson for the federal agency told NPR that its implementation "continues to be a high priority."

The agency stressed the material is inactivated and that the findings "do not represent actual virus that may be a risk to consumers," but it's continuing to study the issue.

Public health authorities are investigating reports of counterfeit injections sickening 19 people across nine states. Experts say getting bona fide Botox starts with finding a trustworthy provider.

At issue in the case is more than abortion rights. It's the entire structure of the FDA's regulatory power to approve drugs and continually evaluate their safety.

At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.